Working… Menu
Trial record 21 of 538 for:    IFNA2 AND RBV AND Hepatitis

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01447394
Recruitment Status : Withdrawn
First Posted : October 6, 2011
Last Update Posted : February 3, 2012
Information provided by (Responsible Party):
Bristol-Myers Squibb

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : March 2014
Estimated Study Completion Date : August 2014